Ciprofloxacin in the treatment of pneumonia.
The use of ciprofloxacin as the sole agent in the treatment of 25 patients with pneumonias caused by susceptible organisms resulted in rapid cure. No side effects, superinfections, or recurrences were observed.
Збережено в:
| Опубліковано в:: | Antimicrob Agents Chemother |
|---|---|
| Автори: | , , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
1986
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180504/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2942104/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.6.1088 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|